Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, a global healthcare leader, has announced a share repurchase program of up to DKK 20 billion over a 12-month period starting February 6, 2024. As part of this program, the company plans to buy back B shares worth DKK 2.4 billion between August 7 and November 4, 2024. By August 30, the firm has repurchased 11,811,313 B shares at an average price of DKK 880.47 each, reflecting a firm commitment to shareholder value.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
